DE FABRITIIS, PAOLA
DE FABRITIIS, PAOLA
Universita' degli Studi di MILANO
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial
2021 F. Gay, P. Musto, D. Rota-Scalabrini, L. Bertamini, A. Belotti, M. Galli, M. Offidani, E. Zamagni, A. Ledda, M. Grasso, S. Ballanti, A. Spadano, M. Cea, F. Patriarca, M. D'Agostino, A. Capra, N. Giuliani, P. de Fabritiis, S. Aquino, A. Palmas, B. Gamberi, R. Zambello, M.T. Petrucci, P. Corradini, M. Cavo, M. Boccadoro
Clinical follow-up of 378 patients with autoimmune hemolytic anemia: prognostic impact of hemoglobin levels, autoantibody class, and reticulocytopenia at onset on the relapse risk and outcome
2017 B. Fattizzo, A. Zaninoni, J.A. Giannotta, M. Lunghi, A. Ferrari, A. Leporace, N. Maschio, L. Scaramucci, S. Cantoni, F. Chiurazzi, D. Consonni, G. Rossi, P. De Fabritiis, G. Gaidano, A. Cortelezzi, W. Barcellini
Clinical follow-up of 378 patients with autoimmune hemolytic anemia: prognostic impact of hemoglobin levels, autoantibody class, and reticulocytopenia at onset on the relapse risk and outcome
2017 B. Fattizzo, A. Zaninoni, J. Giannotta, M. Lunghi, A. Ferrari, A.P. Leporace, N. Maschio, L. Scaramucci, S. Cantoni, F. Chiurazzi, D. Consonni, G. Rossi, P. De Fabritiis, G. Gaidano, A. Cortelezzi, W. Barcellini
The importance of spirituality in supportive care
2011 G. Messina, S. Anania, C. Bonomo, L. Veneroni, A. Andreoli, F. Mameli, C. Ortolina, P. DE FABRITIIS, M. Gaffuri, M. Imbesi, E. Moja